Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:166 Issue:1 Number:1 ISSN#:2564-2537
DOWNLOAD ESPAÑOL
RCT
ACE Report #14210
Ace Report Cover Osteoarthritis

Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis


How to Cite

OrthoEvidence. Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis. ACE Report. 2022;166(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14210

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

Adv Orthop. 2021 Nov 20;2021: 2146722.

Contributing Authors: M Sadat-Ali AS AlOmran SA AlMousa HN AlSayed KW AlTabash MQ Azam TM Hegazi S Acharya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients aged 45-70 years old with knee osteoarthritis were randomized to receive a single intra-articular injection of autologous bone marrow-derived chondrocytes (n=30) or physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Outcomes of interest included pain on a Visual Analog Scale (VAS) with and without movement, the Modified Knee Society Score-Short Form (KSSSF), Activit...

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.